Decreased expression of microRNA-125a-3p upregulates interleukin-23 receptor in patients with Hashimoto’s thyroiditis

Immunologic Research

Volumn 62, Issue 2, 2015, Pages 129-136

  Peng, Huiyong ^a   Liu, Yingzhao ^a   Tian, Jie ^a   Ma, Jie ^a   Tang, Xinyi ^a   Yang, Jun ^a   Rui, Ke ^a   Zhang, Yue ^a   Mao, Chaoming ^a   Lu, Liwei ^b   Xu, Huaxi ^a   Wang, Shengjun ^a  

^a JIANGSU UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autoantibody; Hashimoto s thyroiditis; Interleukin 23 receptor; MicroRNA 125a 3p

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 23 RECEPTOR; MESSENGER RNA; MICRORNA; MICRORNA 125A 3P; THYROGLOBULIN ANTIBODY; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; MIRN125 MICRORNA, DROSOPHILA;

3' UNTRANSLATED REGION; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOITER; HASHIMOTO DISEASE; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RECEPTOR DOWN REGULATION; THYROID GLAND; UPREGULATION; BINDING SITE; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; ADULT; AUTOANTIBODIES; BASE SEQUENCE; BINDING SITES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HASHIMOTO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RECEPTORS, INTERLEUKIN; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84929707697     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8643-3     Document Type: Article

References (21)

1. Nanba T, Watanabe M, Inoue N, et al. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 2009;19(5):495–501.
2. Staii A, Mirocha S, Todorova-Koteva K, et al. Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res. 2010;3(1):11.
3. Zhu C, Ma J, Liu Y, et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 2012;97(3):943–50.
4. Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168(11):5699–708.
5. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24(2):179–89.
6. McGeachy MJ, Chen Y, Tato CM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. 2009;10(3):314–24.
7. Sallusto F, Zielinski CE, Lanzavecchia A. Human Th17 subsets. Eur J Immunol. 2012;42(9):2215–20.
8. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821–52.
9. Dong L, Wang X, Tan J, et al. Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med. 2014;18(11):2213–24.
10. Honardoost MA, Kiani-Esfahani A, Ghaedi K, et al. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Gene. 2014;544(2):128–33.
11. Szmyrka-Kaczmarek M, Kosmaczewska A, Ciszak L, et al. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus. Postepy Hig Med Dosw (Online). 2014;68:893–8.
12. Shi Y, Wang H, Su Z, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand J Immunol. 2010;72(3):250–5.
13. Liu Y, Tang X, Tian J, et al. Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto’s thyroiditis. Int J Mol Sci. 2014;15(12):21674–86.
14. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res. 2011;157(4):163–79.
15. Li Z, Wu F, Brant SR, et al. IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J Immunol. 2011;186(11):6182–90.
16. Chen J, Tian J, Tang X, et al. MiR-346 regulates CD4CXCR5 T cells in the pathogenesis of Graves’ disease. Endocrine. 2015. Online 11 Feb 2015 doi:10.1007/s12020-015-0546-5.
17. Tian J, Rui K, Wang S. Roles of miRNAs in regulating the differentiation and maturation of myeloid-derived suppressor cells. Med Hypotheses. 2014;83(2):151–3.
18. Rapoport B, McLachlan SM. Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab. 2014;99(11):4060–1.
19. Ruggeri RM, Saitta S, Cristani M, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto’s thyroiditis. Endocr J. 2014;61(4):359–63.
20. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953–62.
21. Wang H, Peng W, Ouyang X, et al. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Trans Res. 2012;160(3):198–206.